US Nuclear Corp Reports 54% Reduction in Net Loss, Forecasts Profitability with Nuclear Fusion Investments

US Nuclear Corp (OTC: UCLE) announced a substantial reduction in its net loss for the second quarter, cutting it by over 54% compared to previous periods. The company filed its second-quarter financials, accessible at https://www.sec.gov/edgar/searchedgar/companysearch, and expects trading in its common stock to resume shortly. CEO Bob Goldstein highlighted that excluding a non-cash charge of $451,459 for incentive warrants and a delayed shipment, the net loss for the first half would have been under $301,000, marking a 49% improvement from the $617,404 loss in the first half of 2024.

Goldstein emphasized that the second quarter was nearly breakeven and would have shown a small profit if not for the shipment delay. He projected profitability for the third quarter and the full year, attributing this to a new policy of rejecting low-margin or high-risk jobs. The company is focusing on sustainable growth by prioritizing contracts with better financial returns. This strategic shift is expected to enhance operational efficiency and drive long-term value for shareholders.

Post-quarter, US Nuclear completed two transactions totaling $475,000 with equity partners in the nuclear fusion sector. The company held 622,710 shares in MIFTI, an early-stage firm developing a thermonuclear fusion-powered reactor, and 2 million shares in MIFTEC, focused on radio-isotopes. On September 24, 2025, the entities merged, with MIFTEC shareholders receiving 0.2 MIFTI shares per MIFTEC share, leaving US Nuclear with 1,022,710 MIFTI shares. Goldstein expressed optimism about the merger, stating it aligns with efforts to optimize investments in fission and fusion reactor technologies, which could yield significant upside potential.

Nikki Truax, Director of Operations at Overhoff Technology, the main manufacturing and sales arm, noted plans to expand the sales team to support growing customer demand. The company is integrating product lines from Optron and ECC, resulting in over 250 distinct products. Truax stressed the need for skilled technical salespeople to maintain high service standards. The consolidation and expansion efforts aim to capitalize on the increasing backlog, positioning US Nuclear for stronger performance in 2026 and beyond, as detailed in their financial filings at https://www.sec.gov/edgar/searchedgar/companysearch.